Brain Monitoring Devices Market
The global Brain Monitoring Devices Market was valued at USD 8.9 billion in 2025 and is projected to reach USD 9.8 billion in 2026. The market is expected to reach USD 20.4 billion by 2036, registering a CAGR of 7.6% during the forecast period (2026–2036).
- Published
- Aug 2026
- Pages
- 293
- Format
- PDF + Excel
- Report ID
- MR-2117
- Base year
- 2025
- 2025 · BASELINE
- $8.90B
- 2036
- $20.40B
- CAGR 2026–2036
- 7.6%
2025 baseline · 2026–2036 forecast at 7.6% CAGR · hover a bar for the value
Key highlights
The global Brain Monitoring Devices Market is projected to reach USD 20.4 billion by 2036, driven by the increasing prevalence of neurological disorders, rising incidence of traumatic brain injuries (TBI) and stroke, and growing demand for continuous neurological monitoring in critical care settings.
North America is expected to account for the largest market share in 2026, while Asia-Pacific is projected to register the fastest growth during the forecast period.
By product, Brain Monitoring Devices are expected to account for the largest market share, whereas Software is projected to witness the fastest growth through 2036.
By monitoring modality, Electrical Brain Activity Monitoring is expected to dominate the market, while Multimodal Brain Monitoring is projected to register the fastest growth during the forecast period.
Increasing adoption of AI-powered neurodiagnostics, wearable brain monitoring technologies, and continuous EEG systems is accelerating market growth.
Growing investments in neurotechnology research, digital neurology platforms, and brain-computer interface (BCI) development are creating significant long-term growth opportunities.
Report summary
| Particulars | Details |
|---|---|
| Forecast Period | 2026–2036 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| CAGR (Value) | 7.6% |
| Format | PDF, Excel & Cloud Portal · 293 pages |
| Market Size (Value) in 2026 | USD 9.8 Billion |
| Market Size (Value) in 2036 | USD 20.4 Billion |
| Segments Covered | By Product: Devices, Consumables & Accessories, Software. · By Monitoring Modality: Electrical Brain Activity Monitoring (Routine EEG, Continuous EEG, Ambulatory EEG), Cerebral Oxygenation Monitoring, Intracranial Pressure (ICP) Monitoring, Cerebral Blood Flow Monitoring, Brain Function Monitoring During Anesthesia, Multimodal Brain Monitoring. · By Portability: Fixed Systems, Portable Systems, Wearable Devices. · By Application: Epilepsy Diagnosis & Monitoring, Traumatic Brain Injury (TBI) Monitoring, Stroke Management, Neurosurgery, Intensive Care Monitoring, Anesthesia Monitoring, Sleep Disorder Diagnosis, Brain-Computer Interface (BCI) Research, Cognitive & Mental Health Research. · By End User: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Academic & Research Institutes, Rehabilitation Centers, Home Healthcare Settings. |
| Countries Covered | North America: U.S., Canada.Europe: Germany, U.K., France, Italy, Spain, Netherlands, Rest of Europe.Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, Rest of Asia-Pacific.Latin America: Brazil, Mexico, Argentina, Rest of Latin America.Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa. |
| Key Companies | Medtronic plc, Koninklijke Philips N.V., Nihon Kohden Corporation, Natus Medical Incorporated, Compumedics Limited, Masimo Corporation, GE HealthCare Technologies Inc., Drägerwerk AG & Co. KGaA, Integra LifeSciences Holdings Corporation, Advanced Brain Monitoring, Inc., Neurosoft, Cadwell Industries, Inc., BrainScope Company, Inc., Ceribell, Inc., and Neuroelectrics S.L. |
Report overview
Segments covered: product, monitoring modality, portability, application, end user.
The Brain Monitoring Devices Market comprises medical devices, consumables, software, and analytical platforms used to monitor brain activity, cerebral oxygenation, intracranial pressure, cerebral blood flow, and neurological function across a wide range of clinical settings. These technologies include electroencephalography (EEG) systems, intracranial pressure (ICP) monitors, cerebral oximeters, transcranial Doppler (TCD) systems, electrocorticography (ECoG) systems, bispectral index (BIS) monitors, brain function monitoring systems, and wearable brain monitoring devices. Brain monitoring technologies play a critical role in diagnosing neurological disorders, guiding neurosurgical procedures, monitoring critically ill patients, and supporting precision neurological care.
The market is witnessing steady growth due to the increasing global burden of neurological disorders. According to the World Health Organization (WHO), neurological disorders affect more than one in three people worldwide, making them one of the leading causes of disability and illness globally. In addition, The Lancet Neurology Global Burden of Disease Study reported that neurological conditions accounted for more than 3 billion people living with neurological disorders worldwide, highlighting the growing need for advanced diagnostic and continuous brain monitoring technologies. Rising prevalence of epilepsy, stroke, traumatic brain injury (TBI), Alzheimer's disease, Parkinson's disease, and other neurological conditions is significantly increasing demand for brain monitoring devices across hospitals and specialized neurology centers.
Technological advancements are further accelerating market growth. Artificial intelligence is increasingly being integrated into EEG interpretation, seizure detection, brain signal analysis, and clinical decision support systems, improving diagnostic accuracy and reducing clinician workload. At the same time, wearable brain monitoring devices, wireless EEG systems, cloud-based neurological monitoring platforms, and brain-computer interface (BCI) technologies are expanding the use of brain monitoring beyond traditional hospital environments. Growing investments in neurotechnology research, increasing neurosurgical procedures, and expanding adoption of continuous brain monitoring in intensive care units (ICUs) are expected to support sustained market growth during the forecast period.
Market dynamics
10 factors across 5 forcesRising Prevalence of Neurological Disorders
The increasing prevalence of neurological disorders is one of the primary factors driving demand for brain monitoring devices. Diseases such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis, and brain tumors require accurate diagnosis and continuous neurological monitoring to improve patient outcomes. According to the World Health Organization (WHO), neurological disorders affect more than 3 billion people globally, while dementia affects over 55 million people worldwide, with nearly 10 million new cases diagnosed each year. WHO also estimates that approximately 15 million people experience a stroke annually. As healthcare systems increasingly focus on early diagnosis and long-term neurological care, adoption of advanced brain monitoring technologies is expected to continue growing.
Increasing Incidence of Traumatic Brain Injuries (TBI) and Stroke
The growing incidence of traumatic brain injuries and stroke is significantly increasing the need for continuous brain monitoring across emergency departments, neurosurgical units, and intensive care settings. Brain monitoring devices enable clinicians to assess cerebral function, intracranial pressure, oxygenation, and neurological recovery in real time, supporting timely clinical interventions. According to the U.S. Centers for Disease Control and Prevention (CDC), there were approximately 214,110 traumatic brain injury (TBI)-related hospitalizations in the United States and 68,663 TBI-related deaths in 2023, equivalent to more than 586 hospitalizations and 190 deaths every day. In addition, the World Stroke Organization (WSO) Global Stroke Fact Sheet 2025 reports that the global burden of stroke has increased substantially since 1990, with a 70% rise in incident strokes, an 86% increase in prevalent stroke cases, and a 44% increase in stroke-related deaths. Stroke remains the second leading cause of death and the third leading cause of death and disability worldwide. Increasing emergency admissions, aging populations, and greater awareness of neurological health are expected to sustain demand for advanced brain monitoring systems over the coming years.
Table of contents
13 chapters · 189 sections · 293 pages · click to expandSegmental analysis
| Segment | Largest share (2026) | Fastest growth (2026–2036) |
|---|---|---|
| By Product | Devices | Software |
| By Monitoring Modality | Electrical Brain Activity Monitoring | Multimodal Brain Monitoring |
| By Portability | Fixed Systems | Wearable Devices |
| By Application | Epilepsy Diagnosis & Monitoring | Brain-Computer Interface (BCI) Research |
| By End User | Hospitals | — |
By Product
- Devices are further segmented into Electroencephalography (EEG) Systems, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Transcranial Doppler (TCD) Systems, Electrocorticography (ECoG) Systems, Bispectral Index (BIS) Monitors, Brain Function Monitoring Systems, and Wearable Brain Monitoring Devices.
- Consumables & Accessories include Electrodes, Sensors, Disposable Kits, and Cables & Connectors, while Software comprises Brain Signal Analysis Software, AI-Based Diagnostic Software, and Data Management Platforms.
- The Devices segment is expected to account for the largest share of the global Brain Monitoring Devices Market.
- The large share of this segment is mainly due to widespread adoption of EEG systems, intracranial pressure monitors, cerebral oximeters, and other neurodiagnostic devices across hospitals and neurological care centers.
- However, the Software segment is projected to register the fastest growth during the forecast period.
- The rapid growth of this segment is attributed to increasing adoption of AI-based neurodiagnostic software, automated brain signal analysis, cloud-based data management, and clinical decision support platforms.
By Monitoring Modality
- Electrical Brain Activity Monitoring is further categorized into Routine EEG, Continuous EEG (cEEG), and Ambulatory EEG.
- Electrical Brain Activity Monitoring is expected to account for the largest market share due to its extensive use in diagnosing epilepsy, seizures, encephalopathy, and other neurological disorders.
- However, Multimodal Brain Monitoring is projected to register the highest CAGR during the forecast period as healthcare providers increasingly integrate multiple neurological parameters to improve patient outcomes in neurocritical care.
By Portability
- Fixed Systems are expected to account for the largest market share due to their widespread installation in hospitals, neurology departments, and intensive care units.
- However, Wearable Devices are projected to witness the highest CAGR during the forecast period owing to growing adoption of remote neurological monitoring, home healthcare, and ambulatory EEG solutions.
By Application
- Epilepsy Diagnosis & Monitoring is expected to account for the largest market share because EEG remains the standard diagnostic tool for seizure detection and epilepsy management.
- However, Brain-Computer Interface (BCI) Research is projected to register the highest CAGR during the forecast period due to increasing investments in neurotechnology, AI-enabled brain signal processing, and assistive communication technologies for patients with neurological disabilities.
By End User
- Hospitals are expected to account for the largest market share owing to the high volume of neurological diagnoses, emergency care, neurosurgical procedures, and critical care monitoring performed in hospital settings.mHowever, Home Healthcare Settings are projected to register the highest CAGR during the forecast period, driven by increasing adoption of wearable brain monitoring devices, remote patient monitoring, and tele-neurology services.
Geographic analysis
North America
Largest shareIn 2026, North America is expected to account for the largest share of the global Brain Monitoring Devices Market. The region's leadership is primarily driven by the high prevalence of neurological disorders, advanced healthcare infrastructure, increasing adoption of AI-enabled neurodiagnostic technologies, and strong investments in neuroscience research. The United States has one of the world's largest installed bases of neurodiagnostic equipment and continues to invest heavily in neurological care and brain research. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 795,000 people experience a stroke each year in the United States, while millions of individuals are affected by epilepsy, traumatic brain injuries, and neurodegenerative disorders. Growing adoption of continuous EEG monitoring in intensive care units (ICUs), increasing neurosurgical procedures, and favorable reimbursement for advanced neurodiagnostic technologies continue to strengthen the region's market position.
Asia-Pacific
Fastest growthHowever, Asia-Pacific is projected to register the highest CAGR during the forecast period. Countries such as China, Japan, India, South Korea, Singapore, and Australia are investing significantly in neurological care infrastructure, digital healthcare, and advanced diagnostic technologies. Rising healthcare expenditure, increasing incidence of stroke and neurological disorders, expanding hospital infrastructure, and growing awareness of early neurological diagnosis are driving market growth across the region. Furthermore, increasing adoption of portable and wearable brain monitoring devices, together with government initiatives to strengthen neurological healthcare services, is expected to create substantial growth opportunities in Asia-Pacific during the forecast period.
Competitive landscape
The global Brain Monitoring Devices Market is moderately consolidated, with competition among medical device manufacturers, neurodiagnostic technology providers, patient monitoring companies, and AI-based healthcare software developers. Companies compete primarily on product accuracy, technological innovation, AI-enabled signal analysis, portability, wireless connectivity, ease of use, regulatory approvals, and integration with hospital information systems.
Leading market participants are investing heavily in AI-assisted EEG interpretation, wireless and wearable brain monitoring systems, multimodal monitoring platforms, cloud-based neurological data management, and brain-computer interface technologies. Strategic acquisitions, collaborations with hospitals and neuroscience research institutes, regulatory approvals, and continuous product innovation remain the primary growth strategies adopted by leading companies. Manufacturers are also expanding remote neurological monitoring capabilities to support tele-neurology and home healthcare applications.
The report provides a comprehensive competitive assessment of the leading companies operating in the global Brain Monitoring Devices Market. The key players profiled in the report include Medtronic plc, Koninklijke Philips N.V., Nihon Kohden Corporation, Natus Medical Incorporated, Compumedics Limited, Masimo Corporation, GE HealthCare Technologies Inc., Drägerwerk AG & Co. KGaA, Integra LifeSciences Holdings Corporation, Advanced Brain Monitoring, Inc., Neurosoft, Cadwell Industries, Inc., BrainScope Company, Inc., Ceribell, Inc., and Neuroelectrics S.L.
- Medtronic plc
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Compumedics Limited
- Masimo Corporation
- GE HealthCare Technologies Inc.
- Drägerwerk AG & Co. KGaA
- Integra LifeSciences Holdings Corporation
- Advanced Brain Monitoring, Inc.
- Neurosoft
- Cadwell Industries, Inc.
- BrainScope Company, Inc.
- Ceribell, Inc.
- Neuroelectrics S.L
Frequently asked questions
The global Brain Monitoring Devices Market is estimated at USD 9.8 billion in 2026.
Cite this report
Meticulous Research. (2026). Brain Monitoring Devices Market - Global Opportunity Analysis and Industry Forecast to 2036 (Report No. MR-2117). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/brain-monitoring-devices-market-6800